✦ LIBER ✦

Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

✍ Scribed by Pascale G. Rio; Jean-Claude Maurizis; Monique Peffault de Latour; Yves-Jean Bignon; Dominique J. Bernard-Gallon

Publisher: John Wiley and Sons
Year: 1999
Tongue: French
Weight: 50 KB
Volume: 80
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19990315)80:6<823::aid-ijc5>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genomic deletions in the BRCA1, BRCA2 an

Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma

✍ Rita K. Schmutzler; Erhard Bierhoff; Thorsten Werkhausen; Rolf Fimmers; Paul Spe 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 110 KB 👁 2 views

Sporadic breast carcinoma is associated with multiple genetic alterations. The clinical relevance of these alterations, however, needs further clarification. In the present study we analyzed 266 spontaneously arising breast carcinomas for allelic losses in the BRCA1 and TP53 regions on chromosome 17

Identification of missense and truncatin

Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer

✍ Jill Greenman; Shehla Mohammed; David Ellis; Sally Watts; Gillian Scott; Louise 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

The cloning of the breast and ovarian cancer susceptibility gene, BRCA1, allows direct estimation of the proportion of these cancers in the general population which can be attributed to germline mutations in this gene. We have used a combination of SSCP, heteroduplex analysis, and chemical cleavage

Mutation analysis of the BRCA1 and BRCA2

Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease

✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi

Allelic loss of the BRCA1 and BRCA2 gene

Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset)

✍ Yen-Li Lo; Jyh-Cherng Yu; Chiun-Sheng Huang; Su-Ling Tseng; Tzu-Ming Chang; King 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB

We have examined the role of the breast cancer susceptibility genes BRCA1 and BRCA2 and other loci in the vicinity of these 2 genes on the long arms of chromosomes 17 and 13 (17q and 13q) for the presence of genomic deletions in breast cancer among Taiwanese women. Breast cancer in Taiwan is particu

K-ras mutation and loss of heterozygosit

K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma

✍ N. Peter Zauber; Marlene Sabbath-Solitare; Stephen P. Marotta; D. Timothy Bishop 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## BACKGROUND. The majority of colorectal carcinomas, if not all, arise from a benign adenoma. The DNA of the carcinomatous cells frequently has mutations in several genes. However, it is not exactly clear when during the neoplastic process each mutation develops. An adenoma with an area of in sit